Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sarit T. Kipnis"'
Autor:
David C. Metz, Shria Kumar, Jason M. Heckert, Bryson W. Katona, Caroline Creamer, Alice Alderson, Bonita Bennett, Jennifer R. Eads, Sarit T. Kipnis, Daniel A. Pryma, David A. Mankoff, Michael C. Soulen, Samuel Botterbusch
Publikováno v:
Oncologist
Background Peptide receptor radionuclide therapy (PRRT) is effective for treating midgut neuroendocrine tumors (NETs); however, incorporation of PRRT into routine practice in the U.S. is not well studied. Herein we analyze the first year of PRRT impl
Autor:
Elizabeth Stark, Richard Amdur, Alice R. Knoedler, Patricia Vázquez Rodríguez, Neelima Denduluri, Rebecca Kaltman, Sarit T. Kipnis, Tara Biagi, Nicole Casasanta, Amy Marino, Claudine Isaacs, Laura Linville, Shawn Lipinski, Allision McHenry
Publikováno v:
Clinical breast cancer. 20(2)
Oncotype DX (ODX) is a genomic assay of tumor tissue that is utilized to predict the likelihood of recurrence and benefit of chemotherapy in breast cancer patients. Five to 10% of breast cancers are hereditary, and hereditary syndromes may not be unc
Autor:
Hwan Lee, Sarit T. Kipnis, Michael C. Soulen, David A. Mankoff, Bryson W. Katona, Daniel A. Pryma, Jason M. Heckert, Jennifer R. Eads, Matthew L. Hung, Shria Kumar, David C. Metz, Bonita Bennett
Publikováno v:
JAMA Network Open
This cohort study examines laboratory, clinical, and survival outcomes among patients with gastroenteropancreatic neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy.
Key Points Question What are the clinical outcomes
Key Points Question What are the clinical outcomes
Autor:
Jason Heckert, Sarit T. Kipnis, Jennifer R. Eads, David C. Metz, Caroline Creamer, Bonita Bennett, Bryson W. Katona, Matthew L. Hung, Daniel A. Pryma, David A. Mankoff, Michael C. Soulen
Publikováno v:
Gastroenterology. 158:S-292